Goldman Sachs Starts CVS Health (CVS) at Buy
Tweet
Share
E-mailGet Alerts CVS Hot Sheet
Price: $97.16 +2.28%
Rating Summary:
34 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
34 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Goldman Sachs analyst Scott Fidel initiates coverage on CVS Health (NYSE: CVS) with a Buy rating and a price target of $91.00.
For an analyst ratings summary and ratings history on CVS Health click here. For more ratings news on CVS Health click here.
Shares of CVS Health closed at $78.44 yesterday.
You May Also Be Interested In
- CVS Health (CVS) PT Raised to $118 at JPMorgan
- JPMorgan Resumes SanDisk (SNDK) at Overweight
- New study from CVS Caremark and Employee Benefit News shows how employers rely on their pharmacy benefit manager to create sustainable pharmacy solutions
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
